World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00545194
Date of registration: 16/10/2007
Prospective Registration: No
Primary sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Public title: Cervical Ripening Before Induction of Labour at Term: a Randomised Comparison of Prostin vs Propess
Scientific title: Randomized Study on Removable PGE2 Vaginal Insert Versus PGE2 Intravaginal Gel for Cervical Priming and Labour Induction in Term Pregnancy
Date of first enrolment: January 2002
Target sample size: 446
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00545194
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 3
Countries of recruitment
France
Contacts
Name:     Franck Perrotin, MD-PhD
Address: 
Telephone:
Email:
Affiliation:  Tours Universiity Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- singleton pregnancy

- cephalic presentation

- gestation of more than 37 Weeks confirmed by ultrasound

- Bishop score less than 7

- Informed consent

Exclusion Criteria:

- previous cesarean section (scarred uterus)

- polyhydramnios

- multiple pregnancy

- fetal malformation



Age minimum: 18 Years
Age maximum: 45 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Cervical Ripening
Labor, Induced
Intervention(s)
Drug: Prostaglandin E2
Primary Outcome(s)
Percentage of vaginal deliveries within the 48 hours after cervical ripening [Time Frame: 48 hours]
Secondary Outcome(s)
Arterial base excess more than 12 [Time Frame: 48 hours]
Time to reach 3cm cervical dilatation [Time Frame: 48 hours]
Apgar score at 5 min less or equal 7 [Time Frame: 48 hours]
Arterial pH less or equal 7.20 [Time Frame: 48 hours]
Number of hypertonia with or without fetal heart rate monitoring abnormalities [Time Frame: 48 hours]
Apgar score at 10 min less or equal 7 [Time Frame: 48 hours]
Number of maternal post-partum haemorrhage [Time Frame: 48 hours]
Vaginal deliveries at 12 hours, 24 hours and 36 hours [Time Frame: 48 hours]
Proportion of total vaginal deliveries [Time Frame: 48 hours]
Number of hyperkinesia with or without fetal heart rate monitoring abnormalities [Time Frame: 48 hours]
Secondary ID(s)
PROPESS Study
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history